Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Shambavi Richard
Mount Sinai
10
Talks
38.7k
Listens
Talks
HDP-101: Distinctive Features and Potential Clinical Benefits
July 31, 2026
Share
HDP-101: Distinctive Features and Potential Clinical Benefits
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13234
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HDP-101: Efficacy & Safety Results
July 31, 2026
Share
HDP-101: Efficacy & Safety Results
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13233
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HDP-101: Phase I/IIa Trial Design in Relapsed/Refractory Myeloma
July 31, 2026
Share
HDP-101: Phase I/IIa Trial Design in Relapsed/Refractory Myeloma
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13232
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
HDP-101: An Amanitin-Based BCMA-Targeted Antibody-Drug Conjugate
July 31, 2026
Share
HDP-101: An Amanitin-Based BCMA-Targeted Antibody-Drug Conjugate
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13231
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
DURGA-1 Trial: Conclusion & Key Takeaway
July 31, 2026
Share
DURGA-1 Trial: Conclusion & Key Takeaway
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13230
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
DURGA-1 Trial: Efficacy Results
July 31, 2026
Share
DURGA-1 Trial: Efficacy Results
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13229
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
DURGA-1 Trial: Safety
July 31, 2026
Share
DURGA-1 Trial: Safety
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13228
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
DURGA-1 Trial: Patient Demographics
July 31, 2026
Share
DURGA-1 Trial: Patient Demographics
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13227
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
DURGA-1 Trial: Study Design
July 31, 2026
Share
DURGA-1 Trial: Study Design
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13226
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy
July 31, 2026
Share
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13225
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Why are you reporting this TALK?
